Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Disrupting Stat3 in hair follicle stem cells greatly reduces skin tumor formation.

Mice with human skin protein K8 had more skin problems and cancer.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Tamoxifen caused hair loss in a 52-year-old woman.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Hair follicles can be used to quickly assess drug effects in cancer treatment.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Breast cancer may be detectable through changes in scalp hair lipids.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.